A patient may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, the patient may have surgery or a disability that impairs mobility. Such a patient may use a urinary catheter, such as a Foley catheter, that drains into a drainage bag to address some of these circumstances. However, the visible presence of urine or other bodily fluids in the drainage bag may cause the patient discomfort and/or embarrassment.
Embodiments are directed to drainage bags that include at least one fluid detector, fluid collection systems that include the same, and methods of using the same. In an embodiment, a drainage bag is disclosed. The drainage bag includes one or more walls. At least a portion of the one or more walls is opaque. The one or more walls define at least an inlet and a chamber. The drainage bag also includes at least one fluid detector configured to detect at least one of a presence or quantity of one or more bodily fluids in the chamber.
In an embodiment, a fluid collection system is disclosed. The fluid collection system includes a wheelchair including a plurality of wheels, a seat, and a back rest, the wheelchair forming a front side and a back side opposite the front side. The fluid collection system also includes a drainage bag. The drainage bag includes one or more walls. At least a portion of the one or more walls is opaque. The one or more walls define at least an inlet and a chamber. The drainage bag also includes at least one fluid detector configured to detect at least one of a presence or quantity of one or more bodily fluids in the chamber.
In an embodiment, a method of using a drainage bag is disclosed. The method includes receiving a quantity of one or more bodily fluids into a chamber of the drainage bag. The drainage bag includes one or more walls that defines the chamber. At least a portion of the one or more walls is opaque. The method also includes, responsive to receiving the quantity of the bodily fluids into the chamber, indicating at least one of a presence or quantity of the one or more bodily fluids in the chamber with at least one fluid detector.
Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.
The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.
Embodiments are directed to drainage bags that include at least one fluid detector, fluid collection systems that include the same, and methods of using the same. An example drainage bag includes at least one wall that defines at least a chamber that is configured to receive one or more bodily fluids (e.g., urine, blood, etc.) and an inlet that allows the bodily fluids to enter the chamber. At least a portion of the walls of the drainage bag are opaque thereby reducing a patient's (i.e., a person using the drainage bag) discomfort and/or embarrassment. For example, the walls prevent individuals (e.g., the patient, medical practitioners, visitors, bystanders, etc.) from viewing the bodily fluids in the chamber which would otherwise cause patient discomfort and/or embarrassment. The opaqueness of the walls prevents the patient or medical practitioners from knowing at least one of whether bodily fluids are present in the chamber, the quantity bodily fluids present in the chamber, or when the chamber is full or nearly full. To address this problem, the drainage bag includes at least one fluid detector that is configured to detect at least one of the presence of the bodily fluids in the chamber, the quantity of the bodily fluids that are in the chamber, or when the chamber is full or nearly full. The fluid detector is configured to provide an indication, such as a visual indication, responsive to detecting the bodily fluids.
The drainage bags disclosed herein that include the fluid detector solve several issues of transparent drainage bags. For example, transparent drainage bags allow the bodily fluids present in a chamber thereof to be easily viewed. As such, the presence and quantity of the bodily fluids in the transparent drainage bags may be easily ascertained by the patient and/or other individuals. However, the ability to see the presence and quantity of the bodily fluids in the transparent drainage bags may make the patient uncomfortable and embarrassed. The situation may be exacerbated when the transparent drainage bags are used in public. For instance, transparent drainage bags are not often seen in public and the sight of bodily fluids in the transparent drainage bags may cause stares, pointing, or ridicule. As such, patients who use the transparent drainage bags in public may take steps to prevent bystanders from viewing the bodily fluids in the transparent drainage bags. For example, patients may disposed the transparent drainage bags in an opaque bag. The opaque bag prevents the patient and/or other individuals from determining the presence and quantity of the bodily fluids in the transparent drainage bag without removing the transparent drainage bag from the opaque bag and exposing the transparent drainage bag to the public. Further, the opaque bag may increase the risk that the transparent drainage bag is punctured or leaks due to items disposed in the bag, zippers, etc.
However, walls of the drainage bags disclosed herein are at least partially formed from an opaque material that prevents or at least inhibits viewing of the bodily fluids in the chamber. The drainage bags also include at least one fluid detector that allows for at least one of the presence or quantity of the bodily fluids in such drainage bags to be easily detected. The fluid detector may include, for example, a hydrochromatic ink that changes colors when exposed to the bodily fluids, a pH indicator that changes colors when exposed to the bodily fluids, a hologram, or electrodes. Thus, such drainage bags may be used without causing patient discomfort or embarrassment while also indicating the presence and/or quantity of the bodily fluids therein.
In an embodiment, as illustrated, the one or more walls 106 may be formed from a plurality of walls 106, such as a front wall 114 and a back wall 116. The plurality of walls 106, may be bonded together along the edges thereof to form a fluid tight container. The plurality of walls 106 may be bonded together using an adhesive, heat sealing, ultrasonic welding, induction sealing, or another suitable attachment. In an embodiment, the one or more walls 106 may be formed from a single folded wall or a thin walled cylinder (e.g., formed via a blown film extrusion process). In such an embodiment, the edges of the single folded wall or the thin walled cylinder may be bonded together to form a fluid tight container.
The walls 106 of the drainage bag 102 may be formed from any suitable fluid impermeable material. In an example, the walls 106 of the drainage bag 102 may be formed from a fluid impermeable polymer (e.g., silicone, polyethylene, polypropylene, polytetrafluoroethylene, neoprene, polycarbonate, polyvinyl chloride, etc.), a metal film, natural rubber, another suitable material, or combinations thereof. As such, the walls 106 substantially prevents the bodily fluids from passing through the walls 106. In an example, the walls 106 may be configured to be flexible, rigid, or resilient.
As previously discussed, at least a portion of the walls 106 are opaque. The walls 106 may be opaque when any bodily fluids present in the chamber 109 may not be easily visually identifiable when no backlighting is applied to the drainage bag 102. The opaque portions of the walls 106 may be formed from an opaque material (e.g., silicone, metal foil, etc.) or may be treated to make a transparent material opaque (e.g., painted or coated with an opaque material). In an embodiment, all of the walls 106 are opaque. In an embodiment, the walls 106 may include at least one opaque portion and at least one transparent portion 118. The transparent portion 118 may be at least partially transparent (e.g., translucent). In an example, the transparent portion 118 may allow the patient or another individual to view the fluid detector 104 when the fluid detector 104 is disposed in the chamber 109 or on the interior surface 108. In such an example, the fluid detector 104 may be at least partially opaque and obstruct at least a portion of the transparent portion 118 such that the fluid detector 104 may inhibit viewing the bodily fluids in the chamber 109. In an example, one side of the drainage bag 102 (e.g., the front wall 114) may be opaque and the other side of the drainage bag 102 (e.g., the back wall 116) may be transparent. During use, the transparent side of the drainage bag 102 may be positioned to be adjacent to a structure (e.g., a bed or the portion of a wheelchair) such that the structure inhibits viewing the bodily fluids in the chamber 109 through the back wall 116. However, lifting the drainage bag 102 or otherwise moving the drainage bag 102 away from the structure allows the bodily fluids to be viewed through the transparent side of the drainage bag 102.
Generally, the drainage bag 102 may have any suitable geometry. In the illustrated embodiment, the drainage bag 102 has a generally tear-shaped geometry. However, the drainage bag 102 may have a generally circular geometry (e.g., generally spherical or cylindrical shape when the chamber 109 is filled with bodily fluids), a generally rectangular geometry (e.g., a box-like shape when filled with bodily fluids), or any other suitable shape.
The drainage bag 102 may include a top side 120 and a bottom side 122 opposite the top side 120. During use, the bottom side 122 may be closer to a ground surface (e.g., floor) than the top side 120. The inlet 110 may be located at or near the top side 120 of the drainage bag 102 thereby increasing the quantity of bodily fluids that may be held in the chamber 109 before the level of bodily fluids in the chamber 109 reaches the inlet 110 (i.e., the drainage bag 102 is full). In an embodiment, the drainage bag 102 may include an outlet 124 at or near a bottom side 122 of the drainage bag 102. For example, the outlet 124 may be configured to allow the bodily fluids collected in the drainage bag 102 to flow or drain from the drainage bag 102 (e.g., for collecting or extracting the fluid from the drainage bag 102). For example, the outlet 124 may include the Safety-Flow™ outlet device or another similar outlet device.
As previously discussed, the drainage bag 102 includes at least one fluid detector 104. The fluid detector 104 is configured to detect and provide an indication of the presence and/or quantity of the bodily fluids contained in the chamber 109. In an embodiment, the fluid detector 104 is configured to provide a visual indication of the presence and/or quantity of the bodily fluids in the chamber 109. Examples of fluid detectors that provide a visual indication of the presence and/or quantity of the bodily fluids in the chamber 109 include one or more hydrochromatic inks, one or more pH indicators, or holograms. In an embodiment, the fluid detector 104 is configured to provide one or more electronic signals to a device (e.g., a display, cellphone, etc.) that can display that the fluid detector 104 detected.
Referring to
In an embodiment, the fluid detector 104 includes one or more hydrochromatic inks. The hydrochromatic ink may be configured to exhibit a color change when the hydrochromatic ink comes in contact with the bodily fluids. The color change in the hydrochromatic ink may be caused by water, a major component of bodily fluids, or any other component of the bodily fluids (e.g., salts, urea, proteins, hormones, metabolites, ammonium, phosphorus, potassium, sulfate, plasma, red blood cells, white blood cells, platelets, etc.). The color change of the hydrochromatic ink may include the hydrochromatic ink exhibiting a first color before the hydrochromatic ink comes in contact with the bodily fluids and a second color after the hydrochromatic ink comes in contact with the bodily fluids. The first color is different than the second color. The first and second colors may be independently selected from transparent, any translucent color (e.g., frosted), or any opaque color. In an example, at least the second color is selected to be an opaque color to prevent bystanders from viewing the bodily fluids in the chamber 109. In an example, the color change of the hydrochromatic ink may be irreversible. That is, after exposing the hydrochromatic ink to the bodily fluids, the hydrochromatic may maintain the second color even after the hydrochromatic ink is no longer in contact with the bodily fluids and is dried. In an example, the color change of the hydrochromatic ink may be reversible such that the hydrochromatic ink may revert back to the first color after the hydrochromatic ink is no longer in contact with the bodily fluids and is dried. The reversible hydrochromatic ink may allow the drainage bag 102 to be reusable (i.e., the bodily fluids may be removed from the chamber 109 thereby allowing more bodily fluids to enter the chamber 109). The first and second color of the hydrochromatic ink and whether the hydrochromatic ink is irreversible or reversible may depend on the chemical composition of the hydrochromatic ink.
In an embodiment, the fluid detector 104 includes a pH indicator. Generally, urine exhibits a pH of about 4.5 to about 8, more particularly about 5 to 7, and more particularly about 6. As such, the pH indicator may be selected to exhibit a color change when the pH is between these pH ranges. As such, the pH indicator may include at least one of Congo red, bromocresol green, methyl purple, bromothymol blue, methyl red, bromocresol purple, bromothymol blue, phenol red, neutral red, azolitmin, phenolphthalein, napththolphthalein, cresol red, any other suitable pH indicator, or combinations thereof.
The pH indicator may be used to diagnosis health conditions that may cause the pH of the bodily fluids to be higher or lower than normal. In an example, the pH indicator may be configured to detect a pH of the bodily fluids that is about 5 or less or about 4.5 or less which may indicate acidosis (e.g., diabetic ketoacidosis), dehydration, diarrhea, starvation, or kidney stones. In an example, the pH indicator may be configured to detect a pH of the bodily fluids that is about 7.5 or greater or about 8 or greater which may indicate a urinary tract infection, kidney failure, kidney tubular acidosis, pyloric obstruction, or respiratory alkalosis. In an embodiment, the fluid detector 104 includes a first fluid detector that is configured to detect the presence and/or quantity of the bodily fluids and a second fluid detector that is pH indicator configured to diagnosis health conditions and another fluid detector.
The hydrochromatic inks and/or the pH indicators disclosed herein may be disposed (e.g., printed) on a substrate. In an embodiment, at least a portion of the walls 106 form the substrate. In an embodiment, the substrate may be distinct from the walls 106 of the drainage bag 102. In such an embodiment, substrate may be attached to the walls 106. The substrate that is distinct from the walls 106 may be transparent or opaque. When the substrate is opaque, the substrate may prevent the viewing the bodily fluids in the chamber 109 even when the hydrochromatic ink or the pH indicator is at least partially transparent. In an example, the substrate that is distinct from the walls 106 may exhibit a porosity or textured surface that allows the bodily fluids to reach the hydrochromatic inks or pH indicators. The porosity or textured surface may be necessary when the substrate is opaque and the hydrochromatic inks or pH indicators are positioned between the substrate and the walls 106. The porosity or textured surface may limit the quantity of bodily fluids that contact to hydrochromatic ink or the pH indicator such that the bodily fluids are not easily visually detectable, especially after the hydrochromatic ink or the pH indicator exhibit the color change thereof.
The fluid detector 104 may indicate the quantity of bodily fluids that are present in the drainage bag 102. For example, the fluid detector 104 may include one or more hydrochromatic inks or pH indicators and the fluid detector 104 may extend at least a portion of the distance between the top side 120 and the bottom side 122 of the drainage bag 102. As the drainage bag 102 receives bodily fluids, a portion of the fluid detector 104 may exhibit a color change and the portions of the fluid detector 104 that exhibit the color change may indicate the levels of bodily fluids in the chamber 109. For instance, the chamber 109 may receive a first quantity of bodily fluids in the chamber 109. The first quantity of bodily fluids may be sufficient that the bodily fluids contact a portion of the fluid detector 104. The portions of the fluid detector 104 that come in contact with the first quantity of bodily fluids exhibits a color change while the portions of the fluid detector 104 that do not come in contact with the first quantity of bodily fluids do not exhibit a color change. Thus, the portions of the fluid detector that come in contact with the first quantity of bodily fluids indicates the quantity of bodily fluids in the chamber 109. After receiving the first quantity of bodily fluids, the chamber 109 may receive a second quantity of bodily fluids. The second quantity of bodily fluids causes additional portions of the fluid detector 104 to come in contact with the bodily fluids. Thus, the second quantity of bodily fluids causes further portions of the fluid detector 104 to exhibit a color change. Graduated markings (not shown) may be formed on the exterior surface 107 of the walls 106 to indicate the quantity of bodily fluids in the chamber 109 based on the portions of the fluid detector 104 that exhibits the color change.
As previously discussed, the walls 106 of the drainage bag 102 may include a transparent portion 118 that allows the fluid detector 104 to be seen when the fluid detector 104 is in the chamber 109. The fluid detector 104 may be positioned adjacent to the transparent portion 118. For example, at least a portion of the fluid detector 104 may be attached to the transparent portion 118. The fluid detector 104 may be configured to prevent individuals from viewing the bodily fluids in the chamber 109. In an example, as previously discussed, the fluid detector 104 may be opaque at least after the fluid detector 104 comes in contact with the bodily fluids thereby preventing individuals from viewing the bodily fluids in the chamber 109. In an example, the fluid detector 104 may be configured to cover all or substantially all of the transparent portion 118 thereby restricting individuals from viewing the chamber 109.
The drainage bag 102 may be formed using any suitable technique. In an embodiment, the transparent portion 118 may be formed by forming a hole in opaque walls and attaching a transparent fluid impermeable material to the opaque walls. In an embodiment, the transparent portion 118 may be formed by treating (e.g., painting or coating) all of one or more transparent walls except for a portion of the transparent walls that form the transparent portion 118. In an embodiment, the fluid detector 104 may be disposed (e.g., adhesively attached, printed, etc.) on the interior surface 108 of the walls 106. After disposing the fluid detector 104 on the interior surface 108, one or more edges of the walls 106 may be bonded together.
The drainage bags disclosed herein may exhibit structures other than the structures illustrated in
Referring to
The drainage bag 202 may be formed by forming a hole in the walls 206 of the drainage bag 202. The hole may be formed by cutting or otherwise removing portions of the walls 206 to form the hole, the walls 206 may be provided with the hole, or the hole may be the space between edges of the walls 206 before the walls 206 are bonded together. After forming the hole, the fluid detector 204 may be disposed in the hole or over the hole (e.g., the fluid detector 204 overlaps portions of the walls 206 that define the hole). The fluid detector 204 may then been attached to the portions of the walls 206 that define the hole in a fluid tight manner. For example, the fluid detector 204 may be attached to the walls 206 using tape, an adhesive, ultrasonic welding, or any other suitable attachment technique.
Referring to
In an embodiment, the fluid detector 304 is a hologram. In such an embodiment, the hologram may provide a first visual indication to an individual when the hologram is in a first position and a second visual indication to the individual when the hologram is in a second position that is different than the first position. The hologram may be in the first position when no bodily fluids are in the chamber 309. Disposing bodily fluids in the chamber 309 may cause the walls 306 to bulge outwardly, thereby changing the hologram from the first position to the second position. As such, the second visual indication of the hologram may indicate the presence of the bodily fluids in the chamber 309. In an example, the hologram may only be in the second position when the chamber 309 is full or substantially full. In an example, the fluid detector 304 may include a plurality of holograms and each hologram may provide the second visual indications thereof when a certain quantity of bodily fluids are present in the chamber 309. For instance, the fluid detector 304 may include a first hologram that provides the second visual indication thereof when a first quantity of bodily fluids are in the chamber 309, a second hologram that provides the second visual indication thereof when a second quantity of bodily fluids are in the chamber 309, and so forth.
In an embodiment, the fluid detector 304 may include a visual indicator disposed on or formed on the walls 306 (e.g., a colored, textured, or otherwise distinguishable portion of the walls 306). The walls 306 may include a fold formed therein that covers the visual indicator when substantially no bodily fluids are disposed in the chamber 309. Disposing bodily fluids in the chamber 309 may cause the fold to unfold thereby exposing the visual indicator. In an example, the fluid detector 304 may include a plurality of folds and each fold may display the visual indicator thereof when a certain quantity of bodily fluids are present in the chamber 309. For instance, the fluid detector 304 may include a first fold that displays the visual indicator thereof when a first quantity of bodily fluids are in the chamber 309, a second fold that displays the visual indicator thereof when a second quantity of bodily fluids are in the chamber 309, and so forth.
Referring to
In an embodiment, the fluid detector 404 may be used to retrofit an opaque drainage bag. For example, the opaque drainage bag may have one or more holes 428 formed thereon. After forming the holes 428, the drainage bag 402 is formed by attaching the fluid detector 404 to a portion of the walls 406 in a fluid tight manner to form the secondary chamber 426. The fluid detector 404 is attached to the walls 406 such that the holes 428 are adjacent to and in fluid communication with the secondary chamber 426.
Referring to
In an embodiment, the fluid detector 504 includes at least one capacitor. Each capacitor may include a first electrode 540 and a second electrode 542. In an example, the first and second electrodes 540, 542 are disposed on the front and back walls, 514, 516 of the walls 506, respectively. The presence and/or quantity of the bodily fluids may be detected based on measuring at least one property of the capacitor. The property of the capacitor that may be measured includes at least one of charge density, capacitance, leakage current, or any other properties of the capacitor. For example, the first and second electrode 540, 542 may be spaced from each other by a first distance and one or more first materials (e.g., the walls 506 and, optionally, air) before one or more bodily fluids are introduced into the chamber 509. Disposing the bodily fluids into the chamber 509 may cause the distance and/or materials between the first and second electrodes 540, 542 to change which, in turn, may cause the properties of the capacitor that are being measured to change. In an example, the bodily fluids may cause the distance between the first and second electrodes 540, 542 to increase from the first distance to a second distance. The increased distance between the first and second electrodes 540, 542 may change the properties of the capacitor that are being measured. It is noted that the second distance may correspond to the quantity of bodily fluids that are present in the chamber 509 since increasing the quantity of bodily fluids in the chamber 509 may increase the distance between the first and second electrodes 540, 542. In an example, the bodily fluids may be disposed between the first and second electrodes 540, 542 such that the first and second electrodes 540, 542 are separated by a second material (e.g., the walls 506 and the bodily fluids). The second material may exhibit a dielectric constant (e.g., relative permittivity) that is different than the first material which may change the property of the capacitor that is being measured.
The fluid detector 504 may include detectors other than at least one capacitor. For example, the fluid detector 504 may include at least one of an ultrasound transducer that can detect the bodily fluids, an electronic pH sensor configured to detect the pH of the bodily fluids, a photodetector disposed in the chamber 509 or configured to image at least one hydrochromatic inks and/or at least one pH indicator, a chemiresistor, an electronic nose, a holographic sensor, a humistor, a hydrometer, or any other suitable sensor.
In a particular embodiment, the drainage bags disclosed herein may be used with a patient that uses a wheelchair. The patient may use the wheelchair to access public places. Using the wheelchair in public places may cause the drainage bags to be visible to individuals. However, as previously discussed herein, the opaque walls of the drainage bags disclosed herein may prevent individuals from seeing the bodily fluids in the drainage bag when the drainage bag is used with a wheelchair. However, the particular configuration and structure of the drainage bag may depend on the placement of the drainage bag on the wheelchair.
For example,
The wheelchair 644 may include any generic or specially made wheelchair. For example, the wheelchair 644 may include a manual-self propelled wheelchair, a manual attendant-propelled wheelchair, a powered wheelchair, a mobility scooter, a single-art drive wheelchair, a reclining and/or tilting wheelchair, a standing wheelchair, a sports wheelchair, a wheelchair stretcher, an all-terrain wheelchair, a smart wheelchair, or any other wheelchair. The wheelchair 644 may include a seat 646, a back rest 648, and one or more wheels 650. The wheelchair 644 may include a front side 652, and a back side 654 opposite the front side 652. The front side 652 of the wheelchair 644 is the side of the wheelchair 644 where the legs of the patient are configured to be positioned and may include one or more leg rests (not shown). The back side 654 of the wheelchair 644 is the side of the wheelchair 644 with the back rest 648 and may include one or more handles 658.
In an embodiment, the drainage bag 602 is configured to be positioned on the back side 654 of the wheelchair 644. For example, the drainage bag 602 may be dangled using one or more straps 660 or may be positioned in a pocket. The drainage bag 602 includes a back side (not shown, obscured), a front side 614 opposite the back side 616, a top side 620, and a bottom side 622 opposite the top side 620. The back side 616 of the drainage bag 602 generally faces the front side 652 of the wheelchair 644 and the back side 616 of the drainage bag 602 faces the same direction as the back side 654 of the wheelchair 644. The bottom side 622 of the drainage bag 602 generally faces a ground on which the wheelchair 644 is disposed.
In an embodiment, the fluid detector 604 of the drainage bag 602 may be disposed on at least one of the front side 614 or the top side 620 of the drainage bag 602. Positioning the fluid detector 604 on the front side 614 or the top side 620 allows the fluid detector 604 to be easily viewed by an individual pushing the wheelchair 644 or an individual (e.g., medical practitioner) who stands adjacent to the back side 654 of the wheelchair 644. As such, the fluid detector 604 may be easily and quickly examined. In an embodiment, the fluid detector 604 may be disposed on a side of the drainage bag 602 other than the front side 614 or the top side 620 of the drainage bag 602. Positioning the fluid detector 604 on another side of the drainage bag 602 may require handling (e.g., lifting or twisting) of the drainage bag 602 to view the fluid detector 604 thereby increasing the time and effort required to examine the fluid detector 604. The increased time and effort required to examine the fluid detector 604 may result in the individual checking the fluid detector 604 less often or failing to notice an increase in the rate at which the drainage bag 602 is being filled thereby increasing the risk that the drainage bag 602 becomes overfilled than if the fluid detector 604 is disposed on the front or top side 620, 622 of the drainage bag 602.
The drainage bags disclosed herein may be disposed in other locations on wheelchairs. For example,
The wheelchair 744 includes a shelf 760 that is configured and/or able to hold the drainage bag 702 thereon. The shelf 760 may be positioned under the seat 746 of the wheelchair 744. The drainage bag 702 may be disposed on the shelf.
In an embodiment, the distance between the shelf 760 and the seat 746 may not be sufficient for the drainage bag 702 to dangle such that the length or width of the drainage bag 702 (e.g., the two largest dimensions of the drainage bag 702 measure perpendicularly to each other) is generally parallel to the direction of gravity, as illustrated in
The drainage bag 702 illustrated in
The drainage bags may be used in applications that do not include a wheelchair. In an embodiment, the drainage bags disclosed herein may be used with a patient that is on a bed. In such an embodiment, the drainage bag may be attached to the bed or an object near the bed. For instance, the drainage bag may be dangled from the bed or an object near the bed similar to the drainage bag 602 or may be disposed on a shelf similar to the drainage bag 702. The opaque walls of the drainage bag may prevent visitors to the patient, individuals walking by the patient, or other individuals from viewing the bodily fluids in the chamber of the drainage bag. In an embodiment, the drainage bags disclosed herein may be used with a patient that uses as IV pole. For example, the drainage bag may be attached near the base of the IV pole and the IV pole may allow the patient to walk about a hospital or other facility. The opaque walls may of the drainage bag may prevent visitors to the patient, individuals walking by the patient, individuals the patient walks past in the halls, or other individuals from viewing the bodily fluids in the chamber of the drainage bag. In an embodiment, the drainage bags disclosed herein may be used with patients who are able to walk. In such an embodiment, the drainage bag may be attached to or include a strap that may be positioned over the patient's shoulders, attached to the patient's legs, disposed in a bag, or otherwise carried by the patient. Again, the opaque walls of the drainage bag prevent individuals from viewing the bodily fluids in the drainage bag. In any of the above embodiments, the drainage bag includes at least one fluid detector that allows the patient or another individual to determine the presence and/or quantity of bodily fluids in the chamber of the drainage bag.
As previously discussed, the drainage bags disclosed herein may be connected to a fluid collection assembly.
In some examples, the drainage bags disclosed herein may form part of a fluid collection system that includes a vacuum source that is configured to pull bodily fluids received by the fluid collection assembly into the drainage bag.
During operation, one or more bodily fluids may be discharged from a patient, such as from the urethral opening of the patient. The bodily fluids may flow into the chamber 970 (e.g., through the opening 972) and be received into the porous material 976. The bodily fluids may flow through the porous material 976 towards the inlet 984 of the first drainage tube 912a (e.g., towards the reservoir 982). The vacuum pressure may remove the bodily fluids from the chamber 970, through the first drainage tube 912a, and deposit the bodily fluids in the chamber of the drainage bag 902.
It is noted that the fluid collection assembly 962 illustrated in
While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiments disclosed herein are for purposes of illustration and are not intended to be limiting.
Terms of degree (e.g., “about,” “substantially,” “generally,” etc.) indicate structurally or functionally insignificant variations. In an example, when the term of degree is included with a term indicating quantity, the term of degree is interpreted to mean ±10%, +5%, or +2% of the term indicating quantity. In an example, when the term of degree is used to modify a shape, the term of degree indicates that the shape being modified by the term of degree has the appearance of the disclosed shape. For instance, the term of degree may be used to indicate that the shape may have rounded corners instead of sharp corners, curved edges instead of straight edges, one or more protrusions extending therefrom, is oblong, is the same as the disclosed shape, etc.
This application claims priority to U.S. Patent Provisional Application No. 63/181,695 filed on Apr. 29, 2021, the disclosure of which is incorporated herein, in its entirety, by this reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/026667 | 4/28/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63181695 | Apr 2021 | US |